Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $437.90 | 26 | 65.2% |
| Education | $234.09 | 5 | 34.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $137.15 | 4 | $0 (2018) |
| Incyte Corporation | $124.14 | 3 | $0 (2017) |
| Lilly USA, LLC | $92.12 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $67.42 | 4 | $0 (2018) |
| Janssen Biotech, Inc. | $47.88 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $30.99 | 2 | $0 (2017) |
| Foundation Medicine, Inc. | $29.85 | 2 | $0 (2017) |
| Seattle Genetics, Inc. | $24.58 | 2 | $0 (2019) |
| Jazz Pharmaceuticals Inc. | $22.33 | 1 | $0 (2020) |
| Sysmex Inostics Inc | $18.51 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $22.33 | 1 | Jazz Pharmaceuticals Inc. ($22.33) |
| 2019 | $52.33 | 4 | Puma Biotechnology, Inc. ($15.76) |
| 2018 | $203.82 | 9 | Lilly USA, LLC ($92.12) |
| 2017 | $393.51 | 17 | Incyte Corporation ($124.14) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/06/2020 | Jazz Pharmaceuticals Inc. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/21/2019 | Janssen Biotech, Inc. | Erleada (Drug), DARZALEX | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Oncology | ||||||
| 05/21/2019 | PFIZER INC. | MYLOTARG (Biological), BOSULIF, BESPONSA | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Oncology | ||||||
| 02/26/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 12/12/2018 | AMAG Pharmaceuticals, Inc. | FERAHEME (Drug), MUGARD | Education | In-kind items and services | $17.44 | General |
| Category: PARENTERAL IRON REPLACEMENT | ||||||
| 11/30/2018 | Lilly USA, LLC | VERZENIO (Drug) | Education | In-kind items and services | $92.12 | General |
| Category: Oncology | ||||||
| 09/05/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 01/30/2018 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Oncology | ||||||
| 01/25/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: ONCOLOGY | ||||||
| 01/18/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2018 | Sysmex Inostics Inc | — | Food and Beverage | Cash or cash equivalent | $8.08 | General |
| 01/09/2018 | Sysmex Inostics Inc | — | Food and Beverage | Cash or cash equivalent | $10.43 | General |
| 01/03/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2017 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.95 | General |
| 11/01/2017 | Amgen Inc. | Neulasta (Biological), Vectibix | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Oncology | ||||||
| 10/16/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Oncology | ||||||
| 10/06/2017 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2017 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: BioOncology | ||||||
| 09/28/2017 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Food and Beverage | In-kind items and services | $92.53 | General |
| Category: Oncology | ||||||
| 09/07/2017 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug), DARZALEX, YONDELIS | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: Oncology | ||||||
| 08/22/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $15.37 | General |
| Category: Hematology/Oncology | ||||||
| 07/20/2017 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Oncology | ||||||
| 06/29/2017 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: ONCOLOGY | ||||||
About Dr. David Trent, M.D
Dr. David Trent, M.D is a Hematology & Oncology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043274251.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Trent, M.D has received a total of $671.99 in payments from pharmaceutical and medical device companies, with $22.33 received in 2020. These payments were reported across 31 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($437.90).
Practice Information
- Specialty Hematology & Oncology
- Location Richmond, VA
- Active Since 04/14/2006
- Last Updated 10/18/2012
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1043274251
Products in Payments
- FASLODEX (Drug) $92.53
- VERZENIO (Drug) $92.12
- XTANDI (Drug) $46.99
- TAGRISSO (Drug) $32.49
- FOUNDATIONONE (Device) $29.85
- ADCETRIS (Biological) $24.58
- JAKAFI (Drug) $24.19
- VYXEOS (Drug) $22.33
- Xtandi (Drug) $20.43
- FERAHEME (Drug) $17.44
- AFINITOR (Drug) $16.56
- Nerlynx (Drug) $15.76
- KISQALI (Drug) $14.43
- Erleada (Drug) $13.40
- IMBRUVICA (Drug) $13.15
- IMFINZI (Drug) $12.13
- Neulasta (Biological) $11.10
- Perjeta (Biological) $10.93
- GILOTRIF (Drug) $10.91
- MYLOTARG (Biological) $10.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Richmond
Dr. Victor Yazbeck, M.d, M.D
Hematology & Oncology — Payments: $390,374
Attique Samdani, M.d, M.D
Hematology & Oncology — Payments: $146,382
Dr. Elke Friedman, Md, MD
Hematology & Oncology — Payments: $25,274
Dr. Asit Paul, M.d., Ph.d.,, M.D., PH.D.,
Hematology & Oncology — Payments: $7,490
Dr. Ghulam Qureshi, M.d, M.D
Hematology & Oncology — Payments: $7,032
Gisa-Beate Schunn, M.d, M.D
Hematology & Oncology — Payments: $5,929